Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation

TH17 lymphocytes appear to be essential in the pathogenesis of numerous inflammatory diseases. We demonstrate here the expression of IL-17 and IL-22 receptors on blood-brain barrier endothelial cells (BBB-ECs) in multiple sclerosis lesions, and show that IL-17 and IL-22 disrupt BBB tight junctions in vitro and in vivo. Furthermore, TH17 lymphocytes transmigrate efficiently across BBB-ECs, highly express granzyme B, kill human neurons and promote central nervous system inflammation through CD4+ lymphocyte recruitment.

[1]  Jack P Antel,et al.  Th1 and Th2 lymphocyte migration across the human BBB is specifically regulated by interferon beta and copolymer-1. , 2005, Journal of autoimmunity.

[2]  Qiang Tian,et al.  Expression and regulation of IL-22 in the IL-17-producing CD4+ T lymphocytes , 2006, Cell Research.

[3]  J. Antel,et al.  Regulation of Th1 and Th2 Lymphocyte Migration by Human Adult Brain Endothelial Cells , 2001, Journal of neuropathology and experimental neurology.

[4]  L. Fouser,et al.  Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides , 2006, The Journal of experimental medicine.

[5]  A. Bouthillier,et al.  Angiotensin II Controls Occludin Function and Is Required for Blood–Brain Barrier Maintenance: Relevance to Multiple Sclerosis , 2007, The Journal of Neuroscience.

[6]  S. Szabo,et al.  Loss of T-bet, But Not STAT1, Prevents the Development of Experimental Autoimmune Encephalomyelitis , 2004, The Journal of experimental medicine.

[7]  Lawrence Steinman,et al.  A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of T cell–mediated tissue damage , 2007, Nature Medicine.

[8]  S. Nakae,et al.  IL-17 Plays an Important Role in the Development of Experimental Autoimmune Encephalomyelitis1 , 2006, The Journal of Immunology.

[9]  C. Uyttenhove,et al.  Development of an anti‐IL‐17A auto‐vaccine that prevents experimental auto‐immune encephalomyelitis , 2006, European journal of immunology.

[10]  T. Mcclanahan,et al.  IL-23 drives a pathogenic T cell population that induces autoimmune inflammation , 2005, The Journal of experimental medicine.

[11]  Roland Martin,et al.  Immunology of multiple sclerosis. , 2005, Annual review of immunology.

[12]  P. Valdez,et al.  Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis , 2007, Nature.

[13]  R. Kastelein,et al.  Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain , 2003, Nature.

[14]  T. Owens,et al.  Selective enrichment of Th1 CD45RBlow CD4+ T cells in autoimmune infiltrates in experimental allergic encephalomyelitis. , 1994, International immunology.